Feng Li
National Institutes of Health(US)National Institute on Drug Abuse(US)Guiyang Medical University(CN)Zhejiang University of Science and Technology(CN)Nankai University(CN)Affiliated Hospital of Guizhou Medical University(CN)First Affiliated Hospital of Zhengzhou University(CN)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Nanoparticle-Based Drug Delivery, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Metal complexes synthesis and properties
Most-Cited Works
- → BAP1 links metabolic regulation of ferroptosis to tumour suppression(2018)1,008 cited
- → Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers(2018)144 cited
- → Effective Elimination of Cancer Stem Cells By a Novel Drug Combination Strategy(2012)102 cited
- → Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy(2020)97 cited
- → Nanoplasmonic Sandwich Immunoassay for Tumor-Derived Exosome Detection and Exosomal PD-L1 Profiling(2021)79 cited
- → Intein-mediated site-specific synthesis of tumor-targeting protein delivery system: Turning PEG dilemma into prodrug-like feature(2016)66 cited